$ {alt}

Victims of Severe Brain Trauma to be Studied at UNMH

A lesão cerebral traumática é a principal causa de morte e incapacidade em crianças e adultos até 44 anos de idade. A cada 15 segundos, alguém nos EUA sofre uma lesão cerebral traumática grave e, a cada cinco minutos, alguém fica incapacitado para sempre devido a uma lesão cerebral traumática.

The University of New Mexico Hospital will be conducting a research study to learn if either of two strategies currently used for monitoring and treating patients with severe traumatic brain injury in the intensive care unit (ICU) is more likely to help them get better. Both of these alternative strategies are used in standard care. It is unknown if one is more effective than the other.

Em uma estratégia, os médicos se concentram na prevenção da alta pressão intracraniana causada por um cérebro inchado. Na outra estratégia, os médicos tentam prevenir a alta pressão intracraniana e também tentam prevenir os baixos níveis de oxigênio cerebral. Este estudo descobrirá se qualquer uma das estratégias é mais segura e eficaz.

The study will include adults and children older than 14 years with severe brain injury requiring admission to the ICU with brain monitoring. The research will be part of the Brain Oxygen Optimization in Severe TBI Phase-3 (BOOST-3) study. Hospitals across the country are conducting the study which is funded by the US National Institutes of Health.

Because head injury is a life threatening condition requiring immediate treatment, some patients will be enrolled without consent if a family member or other representative is not rapidly available. Every attempt will be made to locate family prior to enrollment to allow them to decide about the patient's participation in the study. If family is located after enrollment, consent to continue in the study will be sought at the earliest opportunity.

Before the study starts, the research team will consult with the community. Feedback and questions are welcome.

Para mais informações ou para recusar a participação neste estudo, visite or contact the study staff at 505-925-4392.

The study's Primary Investigator is Huy Tran, MD and the Study Coordinator is Ron Mims.